Inflammatory and metabolic biomarkers may help identify patients at risk for difficult to treat rheumatoid arthritis, but ...

Adults with Sjögren disease report substantial non-sicca burdens, including fatigue, pain, and cognitive issues, alongside ...

Adults hospitalized with pneumonia who have a concurrent rheumatoid arthritis diagnosis face a higher risk of death and ...

GLP-1 receptor agonist therapy is linked to a decreased likelihood of knee replacement surgery in patients hospitalized with ...

Patients with interstitial pneumonia with autoimmune features (IPAF) experience increased risks of mortality and health care ...

Tirzepatide therapy is associated with significantly fewer thromboembolic events in rheumatoid arthritis with type 2 diabetes ...

Demographic factors and baseline characteristics have the greatest association with treatment persistence and response among ...

Herbal supplement use is linked to disease onset or flares in dermatomyositis, especially in patients with family autoimmune ...

SGLT2 inhibitors demonstrate greater reductions in incident autoimmune rheumatic disease risk than GLP-1 receptor agonists in type 2 diabetes.

Patients with newly diagnosed Sjögren disease experience treatment delays, high therapy escalation rates, and persistent ...

Long-term treatment retention is similar across advanced therapies in early rheumatoid arthritis, with differences emerging ...

Lower forced vital capacity is associated with death from ILD-related causes in rheumatoid arthritis-associated interstitial ...